Atrys Health (ATRY.MC) Hisse Fiyat
Atrys Health Fiyat
Gelir, son 13 yılda yıllık bileşik %45,5 artarak 141,01 M EUR seviyesine ulaştı. Hisse başına kâr, son 6 yılda yıllık %37,2 geriledi. Atrys Health şirketinde net marj %-71,1 seviyesinde bulunuyor; birkaç yıl önceki %-19,2 seviyesine göre geriledi. Analistler 5,76 EUR medyan fiyat hedefi belirliyor; bu, güncel fiyatın %119,5 üzerinde bir seviyeye işaret ediyor. 10 analistten 9 tanesi hisse için alım öneriyor — genel konsensüs: Al.
Atrys Health hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Atrys Health iş modeli ve hisse analizi
Atrys Health hakkında sık sorulan sorular
The business model of Atrys Health SA revolves around providing advanced medical services and solutions. Atrys is a leading medical technology company that offers specialized diagnostic and therapeutic services, particularly in the fields of oncology, radiology, and molecular medicine. They utilize cutting-edge technology and expertise to deliver accurate diagnoses and personalized treatments to patients. Atrys operates through a network of clinics, laboratories, and telemedicine platforms, ensuring accessibility and quality healthcare solutions. With a focus on precision medicine and innovation, Atrys Health SA aims to improve patient outcomes and contribute to the advancement of the medical field.
Atrys Health SA is primarily active in the healthcare industry.
The main competitors of Atrys Health SA in the market include [Competitor 1], [Competitor 2], and [Competitor 3]. These competitors offer similar products and services, which can create a competitive landscape for Atrys Health SA. However, Atrys Health SA stands out with its unique offerings, such as [mention a unique feature or service]. By maintaining its competitive edge and constantly innovating, Atrys Health SA remains a prominent player in the market, outshining its rivals and ensuring its continued success.
Atrys Health SA is a prominent healthcare company with a rich history and background. Founded in 2008, Atrys Health specializes in medical diagnostic services and telemedicine solutions. With a focus on personalized medicine, the company employs advanced technology and innovative approaches to improve patient care and outcomes. Atrys Health has established a solid reputation in the market by providing high-quality medical services to both public and private institutions. Through strategic partnerships and acquisitions, the company has expanded its operations internationally, becoming a global leader in the field. Atrys Health SA is committed to enhancing healthcare accessibility and efficiency, making significant contributions to the medical industry.
Atrys Health SA, a leading healthcare company, has achieved several significant milestones. It has successfully expanded its reach and offerings, establishing a strong global presence. The company has pioneered advanced medical solutions, leveraging state-of-the-art technology and innovative healthcare practices. Atrys Health SA has consistently focused on delivering excellent patient outcomes, offering personalized diagnostic and treatment services. Its commitment to research and development has led to groundbreaking advancements in areas like molecular diagnostics and telemedicine. With a strong emphasis on collaboration and partnerships, Atrys Health SA continues to revolutionize the healthcare industry, improving access to high-quality medical services worldwide.
Atrys Health SA is primarily present in Spain and several other countries in Europe and Latin America.
Atrys Health SA represents values of excellence, innovation, and patient-centricity. With a dedicated focus on providing advanced medical solutions, Atrys Health combines cutting-edge technology with the expertise of highly skilled professionals. Their corporate philosophy revolves around delivering high-quality healthcare services, improving patient outcomes, and enhancing overall well-being. Atrys Health prioritizes integrity, transparency, and ethical practices in every aspect of their operations. By continuously investing in research and development, Atrys Health aims to revolutionize the healthcare industry and become a global leader in personalized medicine and telemedicine solutions.
Analistler şu anda Atrys Health hissesi için ortalama 5,81 EUR hedef fiyat belirliyor (medyan: 5,76 EUR); bu, son fiyata göre +117,8 % anlamına gelir. Konsensüs 10 analist notuna dayanır.
10 analist şu anda Atrys Health hissesini değerlendiriyor: 9 al, 1 tut, 0 sat öneriyor. 2026 için analistler Atrys Health şirketinin 151,69 M EUR gelir ve 0,01 EUR hisse başına kâr üretmesini bekliyor.
Atrys Health hissesi (ATRY.MC) 3 borsada işlem görür, bunlar arasında: Frankfurt (A2T.F), Madrid (ATRY.MC).
Atrys Health SA is a leading European healthcare company that provides innovative solutions in the field of precision medicine. The company operates in various sectors, including diagnostics, oncology, radiotherapy, and telemedicine. Atrys Health aims to find new ways to improve healthcare by using groundbreaking technology and scientific knowledge. Answer: Atrys Health SA is a leading European healthcare company that provides innovative solutions in the field of precision medicine. The company operates in various sectors, including diagnostics, oncology, radiotherapy, and telemedicine. Atrys Health aims to improve healthcare by using groundbreaking technology and scientific knowledge.
beklenen'nin Atrys Health hasılatı 151,69 M EUR'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Atrys Health karı 881.165,40 EUR'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Atrys Health'nin Fiyat/Kazanç (F/K) oranı şu anda 226,21'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Atrys Health hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Atrys Health'nin Fiyat/Satış (F/S) oranı şu anda 1,31'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Atrys Health hisse senedinin değerleme metriği olarak hizmet eder.
Atrys Health'nin Eulerpool Kalite Puanı 3/10'dur.
Atrys Health'nin ISIN'i ES0105148003'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Atrys Health'nin WKN'i A2JJ74'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Atrys Health'nin ticker'ı ATRY.MC'dir. Ticker sembolü, Atrys Health hisseleri borsada işlem görmek için kullanılır.
Atrys Health Hissesi
Atrys Health Emsaller Grubu
Atrys Health Ticker
Atrys Health FIGI
Atrys Health'nin tüm temel göstergeleri ve derinlemesine analizi
Atrys Health hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Atrys Health şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: